By selecting a country, you will see contents with local focus. Contents that are not available in the local language, will be shown in English.

Healthcare Professionals

Please log in for special information and services

New here?

Germany

- Our Company
  
  We at AOP Orphan are European pioneers in the field of rare diseases, researching, developing, producing, and distributing innovative solutions worldwide since 1996. Learn more about the company here.
  About Our Company
- Rare Diseases and Symptoms
  
  We at AOP Orphan focus on rare diseases particularly in the areas of HematoOncology, Cardiology & Pulmonology, Neurology & Metabolic Disorders. Learn more about the indications, its symptoms, diagnosis, therapies and everyday life here.
  About Rare Diseases and Symptoms
  - HematoOncology
- Individual Treatments
  
  Our strategic goal at AOP Orphan is to constantly deliver new treatment options for the patients with rare disease. Learn more about the current product portfolio and countries' availability here.
  About Individual Treatments
  - HematoOncology
- Join Us
  
  Agile, ambitious and aligned team members, mutual appreciation and commitment - this is what makes AOP Orphan a successful company and great place to work. Learn more about the company, open positions and everyday life at AOP Orphan here.
  About Join Us
  - HR Team & Contacts
  - Jobs
- MPN Awareness Day
  About MPN Awareness Day

Product Overview

Portfolio AOP Orphan

A Product overview with focus on Rare Diseases.

Home
Individual Treatments

Product Overview

AOP Orphan's focus is on Rare Diseases. The portfolio in Germany comprises products in HematoOncology. AOP Orphan’s strategic goal is to constantly deliver new treatment options with respect to Rare Diseases.

HematoOncology

Anagrelide AOP

Drug Facts

Active Ingredient

Anagrelide

HematoOncology

BESREMi®

Drug Facts

Active Ingredient

Ropeginterferon alfa-2b

HematoOncology

Canemes®

Drug Facts

Active Ingredient

Nabilone